Assessment of background levels of autoantibodies as a prognostic marker for severe SARS-CoV-2 infection

BACKGROUND: Patients with more severe forms of SARS-CoV-2 exhibit activation of immunological cascades. Participants (current or ex-smokers with at least 20 years pack history) in a trial (Early Diagnosis of Lung Cancer, Scotland [ECLS]) of autoantibody detection to predict lung cancer risk had seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Frank M., Tello, Agnes, Rauchhaus, Petra, Santiago, Virginia Hernandez, Daly, Fergus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069225/
https://www.ncbi.nlm.nih.gov/pubmed/35517714
http://dx.doi.org/10.33393/jcb.2022.2337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069225/
https://www.ncbi.nlm.nih.gov/pubmed/35517714
http://dx.doi.org/10.33393/jcb.2022.2337

Ejemplares similares